CytoDyn CYDY
OTC CYDY
$0.24 -0.01 (-4.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Shares Outstanding (Diluted) (2020 - 2026)

Updated

CytoDyn (CYDY) recorded Weighted Average Shares Outstanding (Diluted) of 1.38 billion in fiscal Q1 2027 (quarter ended Aug 31, 2026), up 10.4% from 1.25 billion a year earlier and up 7.2% from the prior quarter.

Analysis

CytoDyn (CYDY) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2026 (ended May 31, 2026), CytoDyn reported Weighted Average Shares Outstanding (Diluted) of 1.29 billion, up 3.7% from FY2025.

  • Annual Weighted Average Shares Outstanding (Diluted) has increased for six straight fiscal years, with a five-year compound annual growth rate of 17.0% (FY2021 to FY2026).
  • Across earlier fiscal years, Weighted Average Shares Outstanding (Diluted) came in at 1.24 billion in FY2025 (+28.2%), 969.51 million in FY2024 (+15.9%), 836.53 million in FY2023 (+23.6%) and 676.9 million in FY2022 (+15.2%).
  • The fiscal Q1 2027 figure is the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to fiscal Q4 2020.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for 22 consecutive quarters, with growth averaging 13.3% over the last eight quarters.
  • The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 3.2% (fiscal Q2 2026) and 29.7% (fiscal Q1 2025) over the last five years.
  • Per Business Quant, the preceding three fiscal quarters came in at 1.29 billion (Q4 2026), 1.28 billion (Q3 2026) and 1.26 billion (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.45 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 1.77 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 1.56 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.24 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 5.70 Bn
10 CytoDyn 352.68 Mn 303.84 Mn - 1.38 Bn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 1.38 Bn
May 31, 2026 1.29 Bn
Feb 28, 2026 1.28 Bn
Nov 30, 2025 1.26 Bn
Aug 31, 2025 1.25 Bn
May 31, 2025 1.24 Bn
Feb 28, 2025 1.23 Bn
Nov 30, 2024 1.22 Bn
Aug 31, 2024 1.20 Bn
May 31, 2024 969.51 Mn
Feb 29, 2024 982.21 Mn
Nov 30, 2023 958.99 Mn
Aug 31, 2023 923.59 Mn
May 31, 2023 836.53 Mn
Feb 28, 2023 832.22 Mn
Nov 30, 2022 813.37 Mn
Aug 31, 2022 787.86 Mn
May 31, 2022 676.90 Mn
Feb 28, 2022 695.61 Mn
Nov 30, 2021 662.60 Mn
API Access

CytoDyn Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CYDY&period=max&api_key=YOUR_API_KEY